Riskpilot← Back to searchSign inGet full accessFloda HembioConsult AB
ABActiveOrg 5567940423Byggvägen 3Wholesale of electrical household appliances · NACE 4643Est. 20092 employees
Revenue 2025
SEK 9M
0% vs 2024
EBITDA margin
2.7%
-74% vs 2024
Equity ratio
58.2%
Financial strength
Net profit 2025
SEK 258K
-54% vs 2024
| Revenue | SEK 9M | +0% |
| EBITDA | SEK 245K | -74% |
| Net profit | SEK 258K | -54% |
| Total assets | SEK 6,1M | -8% |
| Equity | SEK 3,6M | +0% |
| Employees | 2 | — |
Legal name
Floda HembioConsult AB
Org number
5567940423
Legal form
Aktiebolag
NACE code
4643 · Wholesale of electrical household appliances
Founded
20 november 2009
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva handel med produkter inom ljud och bild, äga och förvalta fastigheter samt därmed förenlig verksamhet.
Address
Byggvägen 3
Phone
+4630235390
Email
lennart@hembioconsult.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 11 430 | 11 011 | 10 639 | 9 053 | 9 030 |
| Staff expenses | — | −1 079 | −1 121 | −1 337 | −1 383 |
| EBITDA | 895 | 784 | 1 534 | 949 | 245 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 895 | 784 | 1 534 | 949 | 245 |
| Net financials | −110 | −41 | −22 | 15 | 61 |
| Profit before tax | 677 | 695 | 1 190 | 724 | 326 |
| Tax | −147 | −148 | −249 | −158 | −68 |
| Net profit | 530 | 547 | 941 | 566 | 258 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 976 | 5 210 | 6 169 | 6 660 | 6 137 |
| Equity | 2 102 | 2 479 | 3 170 | 3 566 | 3 574 |
| Long-term debt | 474 | 385 | 126 | 63 | 108 |
| Short-term debt | 1 771 | 1 668 | 1 873 | 1 752 | 1 165 |
| Total debt | 2 245 | 2 053 | 1 999 | 1 815 | 1 272 |
EBITDA margin
2.7%
This company
15.8%
Market median
-83% vs market
20212025
Equity ratio
58.2%
This company
38.2%
Market median
+52% vs market
20212025
Return on equity
7.2%
This company
18.4%
Market median
-61% vs market
20212025
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20212025
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20212025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MB Auditor Substitute | Auditor Substitute | 2025 |
| Audit | 2025 | |
| Former (1) | ||
SH Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Floda HembioConsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Birgitta Eriksson | Auditor Substitute | 0 companies |
| Andreas Valdemar Martin Johansson | Audit | 0 companies |
| Sara Helena Katarina Nilsson | Chief Auditor | 0 companies |
| Lennart Erik Gunnar Lingvall | Board of Directors | 0 companies |
| Anna Viktoria Lingvall | Deputy Board Member | 0 companies |